Sanem Asci

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Traumatic Brain Injury

Endothelial Cells

Top Venues

Molecular biology reports

Toxicology mechanisms and methods

This page only lists publications with an associated author ORCID identifier.

Publications

Melike D Unlu, Sanem Asci, Halil Asci, Serife Tasan, Ozlem Ozmen, Rumeysa Taner, Serpil Demirci
Lercanidipine ameliorated doxorubicin-induced neuroinflammation and maintained the expressions of choline acetyltransferase via enhancing the levels of PI3K/AKT/HIF1-α expressions. Molecular biology reports 51 (1) (2024)
Melike D Unlu, Sanem Asci, Halil Asci, Serife Tasan, Ozlem Ozmen, Rumeysa Taner, Serpil Demirci
Lercanidipine ameliorated doxorubicin-induced neuroinflammation and maintained the expressions of choline acetyltransferase via enhancing the levels of PI3K/AKT/HIF1-α expressions. Molecular biology reports 51 (1) (2024)
Mehtap Savran, Sanem Asci, Kanat Gülle, Rahime Aslankoc, Halil Aşçi, Nasif Fatih Karakuyu, Yalcin Erzurumlu, Mine Kaynak
Agomelatine ameliorates doxorubicin-induced cortical and hippocampal brain injury via inhibition of TNF-alpha/NF-kB pathway. Toxicology mechanisms and methods (2023)